News

Researchers from Shenyang University of Chemical Technology explored the application potential of the Catal-GPT in catalyst ...
Innovation doesn’t fail for lack of good ideas. It fails because good ideas are often stranded - too real for research, too ...
In the intersection of artificial intelligence (AI) and catalytic science, researchers at Shenyang University of Chemical Technology have leveraged ...
Figma's land-and-expand business model looks extremely strong due to the stellar 132% net dollar retention rate. Learn why ...
At the Vietnam R&D Forum 2025, experts emphasize that people - not policies or budgets - are the decisive force behind ...
The CHIPS R&D Office is advancing innovation and creating opportunities across industry. TAKEAWAYS $11 billion has been appropriated to the CHIPS Research and Development Office to advance ...
As companies increasingly compete on the basis of technology, brand, and knowledge, a new study reveals that the ...
Fintech firm EMINENCE CAPITAL LTD. today announced a significant increase in its investment in artificial intelligence (AI) ...
Justin Delfino Justin Delfino leads Evalueserve‘s IP and R&D practice, overseeing more than 200+ global experts who deliver innovation intelligence, AI-powered R&D support, and IP strategy services.
But when he arrived at the pharmacy, he was told that the R.S.V. vaccine wasn’t covered by his insurance provider, Anthem Blue Cross Blue Shield. The out-of-pocket cost? About $330.